发明名称 |
Neurosteroids as markers for alzheimer's disease |
摘要 |
One of the major problems with the diagnosis and treatment of neurological diseases is the inability of clinicians to determine the onset of disease. The present invention describes methods and kits whereby the onset of neuropathology is detected by changes in the normal levels of neurosteroids, and particularly DHEA and its metabolic precursors, in the brain and serum. |
申请公布号 |
AU3114201(A) |
申请公布日期 |
2001.08.07 |
申请号 |
AU20010031142 |
申请日期 |
2001.01.26 |
申请人 |
GEORGETOWN UNIVERSITY MEDICAL CENTER |
发明人 |
VASSILIOS PAPADOPOULOS;RACHEL C. BROWN;CATERINA CASCIO |
分类号 |
G01N33/53;A61K45/00;A61P3/00;A61P9/00;A61P17/02;A61P21/00;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P35/00;A61P43/00;G01N33/15;G01N33/50;G01N33/60;G01N33/68;G01N33/74 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|